The Role of Sustained Inflation on Short Term Respiratory Outcomes in Term Infants
1 other identifier
interventional
200
1 country
1
Brief Summary
Sustained inflation (SI) has been reported to be effective for reducing the need for intubation and/or invasive ventilation in preterm infants. However, it has also an important role to support the initial breaths and liquid removal from the airways. Therefore, the investigators hypothesized that SI performed just after birth may help to facilitate the transitional period and decrease the incidence of early respiratory morbidities such as transient tachypnea in term infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2017
CompletedFirst Posted
Study publicly available on registry
May 24, 2017
CompletedStudy Start
First participant enrolled
April 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedAugust 13, 2019
August 1, 2019
1.1 years
May 23, 2017
August 12, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Respiratory Morbidity
RDS, TTN, requirement for supplemental oxygen, intubation or mechanical ventilation support
2 hours
Study Arms (2)
Sustained Inflation Group
EXPERIMENTALIncludes the infants who administered sustained inflation for 5 seconds with a pressure of 30cm H20 immediately after the delivery.
No Intervention group
NO INTERVENTIONIncludes routine neonatal care in the delivery room
Interventions
Administering a pressure of 30 cm H20 by a T-piece resuscitator for 5 seconds immediately after birth.
Eligibility Criteria
You may qualify if:
- term newborns
- parental informed consent
- inborn infants
You may not qualify if:
- major congenital/chromosomal abnormalities
- lack of informed consent
- outborn infants
- Premature infants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Merih Cetinkaya
Kanuni Sultan Suleyman Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, MD,PhD
Study Record Dates
First Submitted
May 23, 2017
First Posted
May 24, 2017
Study Start
April 1, 2018
Primary Completion
May 5, 2019
Study Completion
June 1, 2019
Last Updated
August 13, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share